Upregulation of AKR1B10 in chemotherapy-resistant medulloblastoma D341 and colon cancer HT29 cancer cell lines underscore the utility of this enzyme as a biomarker of drug resistance. The gene discussed is AKR1B10; the disease is malignant colon neoplasm.